市場調查報告書
商品編碼
1535197
呼吸道支架市場:各市場區隔規模,佔有率,法律規章,償付,手術,2033年為止的預測Airway Stents Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033 |
※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。
呼吸道支架是一種中空的管狀裝置,插入呼吸道以緩解阻塞。呼吸道支架又稱為氣管支氣管支架。
呼吸道支架市場受到多種因素的推動,包括人口老化加劇、肺癌發病率上升、良性氣管食道瘺和呼吸道狹窄等呼吸系統疾病、傳染病和結核病。呼吸道支架通常用於患有慢性阻塞性肺病(COPD)等慢性疾病的患者。慢性阻塞性肺病會阻礙氣流並導致呼吸相關問題,例如肺氣腫和慢性支氣管炎。它也主要用於緩解呼吸道阻塞。
本報告提供全球呼吸道支架市場相關資料詳細考察,提供市場上競爭情形,SWOT分析,到2033年為止的市場預測,地區,各國的趨勢等資訊。
Airway Stents Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033 is built to visualize quantitative and qualitative market trends within General Surgery Devices therapeutic area.
An Airway Stent is a hollow tube-shaped device which is inserted into an airway to relieve obstruction. An Airway Stent is also known as a tracheobronchial stent.
The Airway Stents market is driven by a wide variety of factors, including growth of aging populations, increasing incidence of lung cancer, respiratory disorders such as benign tracheoesophageal fistula and airway stenosis, infections, and tuberculosis. Airway stents are largely used in patients with chronic conditions, such as chronic obstructive pulmonary disease (COPD). COPD blocks airflow and causes breathing-related problems such as emphysema and chronic bronchitis. Airway stents are mainly used to relieve airway obstruction.
Each of the covered 39 countries color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes. The interactive excel deliverable covers value, volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.
Key Inclusions of the market model are -
Currently marketed Airway stents and evolving competitive landscape -
Global, Regional and Country level market specific insights -
Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.
Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.
Companies covered: Boston Medical Products Inc, Boston Scientific Corp, Cook Medical Inc, Lymol Medical Corp, Atrium Medical Corp, Merit Medical Systems Inc, Micro-Tech Nanjing Co Ltd, and Others.
Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina and Chile.
This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -
The model will enable you to -